- Vai trò tiên lượng đáp ứng điều trị corticosteroid liều tấn công:
DANH MỤC CÁC CÔNG TRÌNH CÔNG BỐ KẾT QUẢ NGHIÊN CỨU CỦA ĐỀ TÀI LUẬN ÁN
KẾT QUẢ NGHIÊN CỨU CỦA ĐỀ TÀI LUẬN ÁN
1. Nguyen Thi Thu Hien, Pham Van Tran, Le Viet Thang (2020). Servey of plasma IgA, IgG, IgM in pediatric patients with primary nephritic syndrome. Tạp chí Y Dược học Quân sự 1859-0748 (1): 159-165. 2. Nguyễn Thị Thu Hiền, Phạm Văn Trân, Lê Việt Thắng (2020). Khảo sát
nồng độ IgA, IgG, IgM huyết tương ở bệnh nhân có hội chứng thận hư nguyên phát người lớn. Tạp chí Y học Việt Nam, 488 (2), tr: 5-8.
Hướng dẫn chẩn đoán và điều trị một số bệnh về Thận-tiết niệu, 23-27. 2. Phạm Quốc Toản, Nguyễn Thanh Xuân (2019). Chẩn đoán và điều trị
hội chứng thận hư. Cập nhật chẩn đoán, điều trị và dự phòng một số bệnh thận, 121-146.
3. Trần Văn Chất (2015). Hội chứng thận hư. Bệnh thận. Nhà xuất bản Y học.
4. Bệnh viện Nhi Trung ương (2020). Hội chứng thận hư tiên phát ở trẻ em. Hướng dẫn chẩn đoán và điều trị bệnh tre em. NXB Y học, Hà Nội, 42-46.
5. Lai W.L., Yeh T.H., Chen P.M., et al. (2015). Membranous nephropathy: a review on the pathogenesis, diagnosis, and treatment. J Formos Med Assoc., 114 (2):102-11.
6. Matovinović M.S. (2009). Pathophysiology and Classification of
Kidney Diseases.EJIFCC. 20 (1): 2-11.
7. KDIGO Clinical Practice Guideline for Glomerulonephritis (2012). Steroid-sensitive nephrotic syndrome in children. Kidney Int Suppl,
2(2), 163–171.
8. Kodner C. (2009). Nephrotic syndrome in adults: diagnosis and management. Am Fam Physician., 80: 1129-1134.
9. Fleming S. (2014). The kidneys and urinary tract. Muir’s Textbook of pathology 15th edition. 391-419.
10. Almaani S., Meara A., Rovin B.H. (2017). Update on Lupus Nephritis.
Clin J Am Soc Nephrol., 12 (5): 825-835.
11. Lê Việt Thắng (2019). Bệnh thận do đái tháo đường. Cập nhật chẩn đoán, điều trị một số bệnh nội tiết và chuyển hoá hay gặp. Cục Quân Y, 123-129.
patients with nephrotic -range proteinuria. Medicine (Baltimore)., 96(36): e8047.
13. Zajjari Y., Aatif T., Kawtar H., et al. (2018). Histopathological study of
nephrotic syndrome in adults: A Moroccan report. Saudi J Kidney
Dis Transpl., 29 (3): 643-648.
14. Chen Y.M., Liapis H. (2015). Focal segmental glomerulosclerosis:
molecular genetics and targeted therapies. BMC Nephrol., 16: 101-109.
15. Sakamoto K., Ueno T., Kobayashi N., et al. (2014). The direction and role of phenotypic transition between podocytes and parietal epithelial
cells in focal segmental glomerulosclerosis. Am J Physiol Renal
Physiol., 306 (1): F98-F104.
16. Wang J., Cui Z., Lu J., et al. (2014). Circulating Antibodies against Thrombospondin Type-I Domain-Containing 7A in Chinese Patients
with Idiopathic Membranous Nephropathy. Clin J Am Soc Nephrol., 12
(10): 1642-1651.
17. Marinozzi M.C., Roumenina L.T., Chauvet S., et al. (2017). Anti- Factor B and Anti-C3b Autoantibodies in C3 Glomerulopathy and Ig-
Associated Membranoproliferative GN. J Am Soc Nephrol., 28 (5):
1603-1613.
18. Koda R., Nagahori K., Kitazawa A., et al. (2016). Myeloperoxidase Antineutrophil Cytoplasmic Antibody (MPO-ANCA) Associated
Crescentic and Necrotizing Glomerulonephritis ( GN ) with
Membranoproliferative GN Features. Intern Med., 55 (15): 2043-8.
19. Tojo A., Kinugasa S. (2012). Mechanisms of glomerular albumin
21. Sampson M.G., Hodgin J.B., Kretzler M. (2015). Defining nephrotic
syndrome from an integrative genomics perspective. Pediatr Nephrol.,
30 (1): 51-63.
22. Doucet A., Favre G., Deschênes G. (2007). Molecular mechanism of
edema formation in nephrotic syndrome : therapeutic implications.
Pediatr Nephrol., 22 (12): 1983-90.
23. Siddall E.C., Radhakrishnan J. (2012). The pathophysiology of
edema formation in the nephrotic syndrome . Kidney Int., 82 (6):
635-42.
24. Hoorn E.J., Ellison D.H. (2017). Diuretic Resistance. Am J Kidney Dis., 69 (1): 136-142.
25. Ellis D. (2016). Pathophysiology, Evaluation, and Management of
Edema in Childhood Nephrotic Syndrome . Front Pediatr., 3:111.
eCollection 2015.
26. VaziriN.D.(2003).Molecular mechanisms of lipid disorders in nephrotic
syndrome .Kidney Int., 63 (5): 1964-76.
27. Vaziri N.D. (2016). Disorders of lipid metabolism in nephrotic
syndrome : mechanisms and consequences. Kidney Int., 90 (1): 41-52.
28. Agrawal S., Zaritsky J.J., Fornoni A., et al. (2017). Dyslipidaemia in
nephrotic syndrome : mechanisms and treatment. Nat Rev Nephrol.,
14 (1): 57-70.
29. Jeong E.G., Hyoun S., Lee S.M., et al. (2017). Clinical outcomes of
nephrotic syndrome in globulin miễn dịcha nephropathy. Saudi J
Assoc J., 20 (3): 186-189.
31. Wang C.S., Yan J., Palmer R., et al. (2017). Childhood Nephrotic
Syndrome Management and Outcome: A Single Center Retrospective
Analysis.Int J Nephrol., 12 (8): 123-131.
32. Kodner C. (2016). Diagnosis and Management of Nephrotic
Syndrome in Adults. Am Fam Physician. 93 (6): 479-85.
33. Hjorten R., Anwar Z., Reidy K.J., et al. (2016). Long-term Outcomes
of Childhood Onset Nephrotic Syndrome . Front Pediatr., 4:53.
eCollection.
34. Tapia C., Bashir K. (2018). Nephrotic Syndrome . Treasure Island (FL): 345-367.
35. Yaseen A., Tresa V., Lanewala A.A., et al. (2017). Acute kidney injury
in idiopathic nephrotic syndrome of childhood is a major risk factor for
the development of chronic kidney disease.Ren Fail., 39 (1): 323-327.
36. Sharma M., Mahanta A., Barman A.K., et al. (2018). Acute kidney
injury in children with nephrotic syndrome : a single-center study. Clin
Kidney J., 11 (5): 655-658.
37. Huang M.J, Wei R.B., Su T.Y., et al. (2016). Impact of acute kidney
injury on coagulation in adult minimal change nephropathy. Medicine
(Baltimore)., 95 (46): e5366.
38. Rheault M.N., Zhang L., Selewski D.T., et al. (2016). AKI in Children
Hospitalized with Nephrotic Syndrome . Clin J Am Soc Nephrol., 10
(12): 2110-8.
39. Keskar V., Jamale T.E., Kulkarni M.J., et al. (2015). Minimal-change disease in adolescents and adults: epidemiology and therapeutic
(7): 1385-1386.
41. Kapoor K., Saha A., Thakkar D., et al. (2015). Meningitis and
intracranial bleed in a child with steroid-resistant nephrotic syndrome .
Saudi J Kidney Dis Transpl., 26 (6): 1270-3.
42. Soares S.F., Donatti T.L., Souto F.J. (2014). Serological markers of
viral, syphilitic and toxoplasmic infection in children and teenagers
with nephrotic syndrome : case series from Mato Grosso State, Brazil.
Rev Inst Med Trop Sao Paulo., 56 (6): 499-504.
43. Kerlin B.A., Ayoob R., Smoyer W.E. (2012). Epidemiology and
pathophysiology of nephrotic syndrome -associated thromboembolic
disease.Clin J Am Soc Nephrol., 7 (3): 513-20.
44. Hârza M., Ismail G., Mitroi G., et al. (2013). Histological diagnosis and risk of renal vein thrombosis, and other thrombotic complications
in primitive nephrotic syndrome . Rom J Morphol Embryol., 54 (3):
555-60.
45. Kara A., Gurgoze M.K., Serin H.M., et al. (2018). Cerebral arterial
thrombosis in a child with nephrotic syndrome .Niger J Clin Pract., 21
(7): 945-948.
46. Park S.J., Shin J.I. (2011). Complications of nephrotic syndrome .
Korean J Pediatr., 54 (8): 322-8.
47. Lê Việt Thắng, Lê Bích Thuận (2011). Liên quan nồng độ testosterone huyết thanh với một số đặc điểm bệnh nhân nam hội chứng thận hư nguyên phát. Tạp chí Y học thực hành, 9 (783), 54-57.
48. Phạm Thị Phương, Lê Việt Thắng (2013). Khảo sát nồng độ hormon tuyến giáp FT3, FT4 và TSH máu ở bệnh nhân hội chứng thận hư nguyên phát. Tạp chí Y học thực hành, 8 (878), 14-16.
Korean J Pediatr., 13 (8): 114-121.
50. El-Mashad G.M., El-Hawy M.A., El-Hefnawy S.M., et al. (2017).
Bone mineral density in children with idiopathic nephrotic syndrome .J
Pediatr (Rio J)., 93 (2): 142-147.
51. Leon J., Pérez-Sáez M.J., Uffing A., et al. (2018). Effect of Combined Gluten-Free, Dairy-Free Diet in Children With Steroid-
Resistant Nephrotic Syndrome : An Open Pilot Trial. Kidney Int Rep., 3
(4): 851-860.
52. Trautmann A., Lipska-Ziętkiewicz B.S., Schaefer F. (2018). Exploring
the Clinical and Genetic Spectrum of Steroid Resistant Nephrotic
Syndrome : The PodoNet Registry. Front Pediatr., 6:200. eCollection.
53. Pokrajac D., Kamber A.H., Karasalihovic Z. (2018). Children with
Steroid-Resistant Nephrotic Syndrome : A Single –Center Experience.
Mater Sociomed., 30 (2): 84-88.
54. Trautmann A., Vivarelli M., Samuel S., et al. (2020). IPNA clinical practice recommendations for the diagnosis and management of
children with steroid-resistant nephrotic syndrome. Pediatric
Nephrology., 35: 1529–1561.
55. Bộ Y tế (2015). Hội chứng thận hư tiên phát ở trẻ em. Hướng dẫn chẩn đoán và điều trị một số bệnh thường gặp ở tre em, 424-429.
56. Iijima K., Hamahira K., Kobayashi A., et al. (2000).
Immunohistochemical analysis of renin activity in chronic cyclosporine
nephropathy in childhood nephrotic syndrome . J Am Soc Nephrol., 11
(12): 2265-71.
57. Yamazaki M., Fukusumi Y., Kayaba M., et al. (2016). Possible role for
glomerular-derived angiotensinogen in nephrotic syndrome . J Renin
Exacerbated by Furosemide.Cell Physiol Biochem., 45 (4): 1700-1706. 59. Toledo L.A.K., Noblat A.C.B., Nascimento H.F.D., et al. (2017).
Economic evaluation of human albumin use in patients with nephrotic
syndrome in four Brazilian public hospitals: pharmacoeconomic study.
Sao Paulo Med J., 135 (2): 92-99.
60. Duffy M., Jain S., Harrell N., et al. (2015). Albumin and Furosemide
Combination for Management of Edema in Nephrotic Syndrome : A
Review of Clinical Studies.Cells., 4 (4): 622-30.
61. Giordano M., De Feo P., Lucidi P., et al. (2001). Effects of dietary protein restriction on fibrinogen and albumin metabolism in
nephrotic patients. Kidney Int., 60 (1): 235-42.
62. Lemley K.V., Faul C., Schramm K., et al. (2016). The Effect of a
Gluten-Free Diet in Children With Difficult-to-Manage Nephrotic
Syndrome .Pediatrics., 138 (1). Pii: e20154528.
63. Gonzalez-Quintela A., Alende R., Gude F., et al. (2008). Serum levels of
immunoglobulins (IgG, IgA, IgM) in a general adult population and
their relationship with alcohol consumption, smoking and common
metabolic abnormalities. Clin Exp Immunol., 151 (1): 42-50.
64. Schroeder H.W., Cavacini L. (2010). Structure and Function of Immunoglobulins. J Allergy Clin Immunol., 125 (202): S41-S52.
65. Nimmerjahn F., Ravetch J.V. (2007). FC-receptors are regulators of immunity. Adv Immunol., 96: 179-204.
66. Aryal S. (2018). Globulin miễn dịchA (IgA): Structure, Subclasses and Function. https://microbenotes.com/immunoglobulin-a-iga-structure- subclasses-and-functions/
subclasses-and-functions/
68. Boes M. (2000). Role of natural and immune IgM antibodies in immune responses. Mol Immunol., 37:1141-9.
69. Aryal S. (2018). Globulin miễn dịchM (IgM): Structure, Subclasses and Function. https://microbenotes.com/immunoglobulin-m-igm-structure- and-functions/
70. Grönwall C., Vas J., Silverman G.J. (2012). Protective roles of natural IgM antibodies. Front Immunol., 3: 66-74.
71. Canetta P.A., Kiryluk K., Appel G.B. (2014). Glomerular diseases : emerging tests and therapies for IgA nephropathy . Clin J Am Soc Nephrol., 9 (3): 617-25.
72. Wiggins R.C., Alpers C.E., Holzman L.B. (2014). Glomerular disease:
looking beyond pathology. Clin J Am Soc Nephrol., 9 (6): 1138-40.
73. Alsharidah A.S., Alzogaibi M.A., Bayoumy N.M., et al. (2017).
Neutrophil chemokines levels in different stages of nephrotic
syndrome .Saudi J Kidney Dis Transpl., 28 (6): 1256-1263.
74. Guimarães F.T.L., Melo G.E.B.A., Cordeiro T.M., et al. (2018). T- lymphocyte-expressing inflammatory cytokines underlie persistence of
proteinuria in children with idiopathic nephrotic syndrome . J Pediatr
(Rio J)., 94 (5): 546-553.
75. Juozapaite S., Cerkauskiene R., Laurinavicius A. et al. (2018). The
impact of IgM deposits on the outcome of Nephrotic syndrome in
children.BMC Nephrol., 18 (1): 260-269.
76. Winearls C.G. (2015). Clinical assessment of the patient with renal disease: overview. Oxford Texbook of Nephrology. Chapter 2.
Biopsy. Biomed Res Int., 3480309. eCollection.
78. Siji A., Karthik K.N., Pardeshi V.C., et al. (2018). Targeted gene panel for genetic testing of south Indian children with steroid resistant
nephrotic syndrome .BMC Med Genet., 19 (1): 200-212.
79. Chaves M.M.S., Mendes M.S., Schwermann M.P., et al. (2018).
Angiopoietin-2: A Potential Mediator of the Glycocalyx Injury in
Adult Nephrotic Patients.J Clin Med., 7 (11). Pii: E401.
80. Iwabuchi Y., Miyabe Y., Makabe S., et al. (2018). Comparison of the response of frequently relapsing steroid-dependent minimal change
nephrotic syndrome to rituximab therapy between childhood-onset and
adult-onset disease. Medicine (Baltimore). 97 (42): e12704.
81. Zhu H., Han Q., Zhang D., et al. (2018). A diagnostic model for minimal change disease based on biological parameters. Peer J., 6: e4237. eCollection.
82. Dumas De La Roque C., Prezelin-Reydit M., Vermorel A., et al. (2018). Idiopathic Nephrotic Syndrome : Characteristics and
Identification of Prognostic Factors. J Clin Med., 7 (9). Pii: E265.
83. Youssef D.M., Salam S.M., Karam R.A. (2011). Prediction of steroid
response in nephrotic syndrome by humoral immunity assessment.
Indian J Nephrol., 21 (3):, 186-90.
84. Anis S., Parveen J., Musharraf W., et al. (2017). Can we use serum and urine globulin miễn dịchlevels as biomarkers in patients with glomerulonephritis? Immunopathol Persa., 3 (2): e10.
85. Chen C.H., Wu H.Y., Wang C., et al. (2016). Proteinuria as a therapeutic target in advanced chronic kidney disease: a retrospective multicenter cohort study. Sci Rep., 6:26539.
(3): 239- 48.
87. Roy R.R., Roy E., Rahman M.H., et al. (2009). Serum globulin miễn dịchG, M and IgG:IgM ratio as predictors for outcome of childhood nephrotic syndrome. World J Pediatr., 5: 127- 31.
88. Rocchetti M.T., Papale M., Gesualdo L. (2010). Urine Protein Profiling in Globulin miễn dịchA Nephropathy. US Nephrol., 5:56- 63. 89. Tesch G.H. (2010). Serum and urine biomarkers of kidney disease: A
pathophysiological perspective. Nephrology (Carlton)., 15: 609-16 90. Li Y., Wang J., Zhu X., et al. (2012). Urinary protein markers predict
the severity of renal histological lesions in children with mesangial proliferative glomerulonephritis. BMC Nephrol., 13: 29-38.
91. Tofik R., Aziz R., Reda A., et al. (2011). The value of IgG-uria in predicting renal failure in idiopathic glomerular diseases. A long-term follow-up study. Scand J Clin Lab Invest., 71: 123-8.
92. Bakoush O., Segelmark M., Torffvit O., et al. (2006). Urine IgM excretion predicts outcome in ANCA-associated renal vasculitis.
Nephrol Dial Transplant., 21: 1263-9.
93. Nakayama K., Ohsawa I., Maeda-Ohtani A., et al. (2008). Prediction of diagnosis of globulin miễn dịchA nephropathy prior to renal biopsy and correlation with urinary sediment findings and prognostic grading. J Clin Lab Anal., 22: 114-8.
94. Vũ Thị Thơm, Nguyễn Quỳnh Hương, Phạm Văn Đếm và cộng sự (2018). Xét nghiệm gen cho trẻ em mắc hội chứng thận hư tiên phát kháng corticosteroid: Cần thiết hay không? Tạp chí Đại học quốc gia Hà nội, 34 (1),11 – 19.
nghiên cứu Y học, 80 (3), 46 – 52.
96. Phạm Văn Đếm, Nguyễn Thu Hương, Nguyễn Thị Quỳnh Hương và cộng sự (2016). Đặc điểm lâm sàng, cận lâm sàng và kết quả điều trị hội chứng thận hư kháng thuốc steroid tại khoa Thận – lọc máu, Bệnh viện nhi Trung ương. Tạp chí Đại học quốc gia Hà nội, 32 (1), 41 -46. 97. Đỗ Thị Tính (2010). Đặc điểm lâm sàng, cận lâm sàng của hội chứng
thận hư điều trị tại khoa Thận, Bệnh viện Việt Tiêp Hải phòng năm 2008. Tạp chí Y học thực hành, 5 (716), 88 -90.
98. Bộ Y tế (2015). Bệnh Lupus ban đỏ hệ thống. Hướng dẫn chẩn đoán và điều trị các bệnh cơ, xương, khớp, 18-24.
99. ADA (2020). Classcification and Diagnosis of Diabetic Mellitus: Standards of Medical Care in Diabetes. Diabetes Care, 43(1): s14-s20. 100. Hội tim mạch Việt Nam (2015). Cập nhật khuyến cáo chẩn đoán và
điều trị tăng huyết áp 2015, 1-17.
101. Flynn J.T., Kaelber D.C., Baker-Smith C.M., et al. (2017). Clinical Practice Guideline for Screening and Management of High Blood Pressure in Children and Adolescents. Am Acad Pediatr, 140(3): 74.
102. Gupta S., Pepper R.J., Ashman N., et al. (2018). Nephrotic Syndrome:
Oedema Formation and Its Treatment With Diuretics. Front Physiol., 9: e1868.
103. Shatat I.F., Becton L.J., Woroniecki R.P. (2019). Hypertension in
Childhood Nephrotic Syndrome. Front Pediatr., 7: 287-298.
104. Ray E.C., Rondon-Berrios H., Boyd C.R., et al. (2015). Sodium
Retention and Volume Expansion in Nephrotic Syndrome: Implications for Hypertension. Adv Chronic Kidney Dis., 22 (3): 179–184.
88.
106. Kumar M., Malhotra A., Gupta S., et al. (2017). Thromboembolic
complications at the onset of nephrotic syndrome. Sudan J Paediatr., 17 (2): 60–63.
107. Yadav V.K., Sharma S., Debata P.K., et al. (2017). Change in Bone
Mineral Density and Role of Vitamin D and Calcium Supplementation During Treatment of First Episode Nephrotic Syndrome. J Clin Diagn Res., 11 (9): SC18–SC21.
108. Tumlina J.A., Campbellb K.N. (2018). Proteinuria in Nephrotic Syndrome: Mechanistic and Clinical Considerations in Optimizing Management. Am J Nephrol., 47 (suppl 1): 1–2.
109. El-Mashad G.M., El-Hady-Ibrahim S.A., Allah-Abdelnaby S.A. (2017).
Globulin miễn dịchG and M levels in childhood nephrotic syndrome :
two centers Egyptian study. Electron Physician., 9 (2): 3728–3732.
110. Dong J., Peng T., Gao J., et al. (2018). A pilot and comparative study
between pathological and serological levels of globulin miễn dịchand complement among three kinds of primary glomerulonephritis. BMC Immunol., 19: e18.
111. Cuadrado M.J., Calatayud I., Urquizu-Padilla M., et al. (2019).
Globulin miễn dịchabnormalities are frequent in patients with lupus nephritis. BMC Rheumatol., 3: e30.
112. Connor T.M., Aiello V., Griffith M., et al. (2017). The natural history of
globulin miễn dịchM nephropathy in adults. Nephrol Dial Transplant.,
32 (5): 823–829.
113. Al-Assadi A.B., Mohammed N.A., Ali S.H. (2018). Serum Globulin miễn dịchG, M and A Levels in Children with Nephrotic Syndrome and
114. Zhou J., Shi F., Xun W. (2018). Leptin, hs-CRP, IL-18 and urinary protein before and after treatment of children with nephrotic syndrome.
Exp Ther Med., 15 (5): 4426–4430.
115. Rybi-Szumińska A., Wasilewska A., Michaluk-Skutnik J., et al. (2015).
Are oxidized low-density lipoprotein and C-reactive protein markers of atherosclerosis in nephrotic children? Ir J Med Sci., 184 (4): 775–780. 116. Garg P., Verma R., Nihalani D., et al. (2007). Neph1 cooperates with
nephrin to transduce a signal that induces actin polymerization. Mol Cell Biol., 27: 8698–8712.
117. Roselli S., Gribouval O., Boute N., et al. (2002). Podocin localizes in